• / Free eNewsletters & Magazine
  • / My Account
Home>AstraZeneca Agrees to Buy Almirall

AstraZeneca Agrees to Buy Almirall

3party Content

Wed, 30 Jul 2014

LONDON--AstraZeneca PLC (AZN.LN), a British-Swedish pharmaceutical company, said Wednesday it has agreed to buy the rights to Almirall SA's (ALM.MC) respiratory franchise for an initial consideration of $875 million on completion, and up to $1.22 billion in development, launch and sales-related
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.